Where does Placon Therapeutics, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Placon Therapeutics, Inc. ranks #25,005 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Placon Therapeutics, Inc. hold?

Placon Therapeutics, Inc. holds 11 US utility patents granted between 2016 and 2019, spanning 4 technology areas.

What is Placon Therapeutics, Inc.'s Innovation Score?

Placon Therapeutics, Inc. has an Innovation Score of 22.6 out of 100 (10th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Placon Therapeutics, Inc.'s patent grant rate increasing or decreasing?

Placon Therapeutics, Inc.'s recent grant velocity is -100% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Placon Therapeutics, Inc.'s patents?

Placon Therapeutics, Inc.'s patents average 11.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Placon Therapeutics, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Placon Therapeutics, Inc.

Q: What technology areas does Placon Therapeutics, Inc. focus on?

Placon Therapeutics, Inc.'s top technology area is C07F (Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium) with 10 patents, ranking #157 of 1,317 assignees active in that subclass. Grants appear in 4 CPC subclasses total.

USPTO PatentsView assignee record - 11 granted patents across 4 technology areas, recorded in grant years 2016–2019. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07F (Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Placon ranks #25,005 of 49,997 tracked US assignees by granted-patent volume, with 11 patents across 4 technology areas.

#25,005
of 49,997 US assignees by volume: 10th percentile
by Innovation Score (22.6/100): 11.6
avg claims per patent: -100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R25005 · US Corporation #25,005 · 11 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-PAR · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 11 grants
MID-PACK #25,005/49,997
PHOTO-FINISH Phillips Screw
CPC-NARROW C07F · 4 areas
INNOV-THIN 22.6/100
CLAIMS-PAR 11.6 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -100% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Phillips Screw Company (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Placon’s 22.6 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.6 pts (38%) Velocity 0.0 pts (0%) Breadth 7.1 pts (31%) Claim depth 6.9 pts (31%)

Qualcomm Incorporated · highest

85
Placon Therapeutics · this assignee

23
3D Lighting… · lowest

7

What this shows Placon's Innovation Score is 22.6/100 (10th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Placon?

Each dot is one of Placon’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Placon’s own 11.6 claims/patent is at or below the 16.6 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Placon vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Placon's grants concentrate

Placon Therapeutics, Inc. is a focused PatentsView assignee: 4 CPC subclasses with 90.9% of grants classified under C07F (Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium). Peak complete grant year is 2019 (4 grants) versus a trough of 1 in 2016. By volume, Placon sits between Phillips Screw Company and Powergene Technology Co., Ltd., Taiwan Branch.

Phillips Screw

11
Phunware

11
Pimera

11
Pinnpack Packaging

11
PMT

11
PMV Pharmaceutica…

11
Poviva

11
Powergene Technol…

11
Placon Therapeuti… ◀

11

What this shows Placon holds 11 patents at rank #24,965, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Placon

By rank, the assignees closest to #24,965 in granted patent volume.

Leaders in C07F (Acyclic)

Other assignees with the most granted patents in Placon's primary technology class.

Placon's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

23 10th percentile higher than 10% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2019

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Placon Therapeutics, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	1	9.1%
2017	3	27.3%
2018	3	27.3%
2019	4	36.4%

Which technologies does Placon Therapeutics, Inc. patent most?

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 10

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 8

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 7

Y10T - Technical Subjects Covered BY Former US Classification 2

Top 4 of 4 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Placon Therapeutics, Inc.'s patent record in context - here's where to go next.

Placon Therapeutics, Inc.'s lead technology class is C07F (Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium), 90.9% of its portfolio - see every assignee active in that class. Explore C07F
Ranked #25,005 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Placon Therapeutics, Inc. against Phillips Screw Company, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 22.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.